BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35071494)

  • 1. Development of a novel necroptosis-associated miRNA risk signature to evaluate the prognosis of colon cancer patients.
    Huang Y; Zou Y; Xiong Q; Zhang C; Sayagués JM; Shelat VG; Wang X
    Ann Transl Med; 2021 Dec; 9(24):1800. PubMed ID: 35071494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma.
    Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A
    Front Oncol; 2022; 12():941156. PubMed ID: 36505813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.
    Zhang Q; Luo Y; Zhang S; Huang Q; Liu G
    Sci Rep; 2024 Feb; 14(1):4257. PubMed ID: 38383747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs.
    Yu Z; Lu C; Lu B; Gao H; Liang R; Xiang W
    BMC Genomics; 2023 Mar; 24(1):162. PubMed ID: 36991314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Defined Necroptosis-Related miRNAs Signature for Predicting the Prognosis of Colon Cancer.
    Yang Z; Lu S; Wang Y; Tang H; Wang B; Sun X; Qu J; Rao B
    Int J Gen Med; 2022; 15():555-565. PubMed ID: 35046713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
    Zheng L; Wang J; Jiang H; Dong H
    Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma.
    Zhang J; Liu Z; Chen W; Liu H
    Transl Cancer Res; 2023 Sep; 12(9):2239-2255. PubMed ID: 37859737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Necroptosis-Related miRNA Signature as a Potential Predictive Biomarker for Prognosis and Immune Status in Colon Adenocarcinoma.
    Ma X; Yang B; Dong H; Lin H; Wang W
    J Oncol; 2022; 2022():9413562. PubMed ID: 36065304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering a Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Clear Cell Renal Carcinoma.
    Bao JH; Li JB; Lin HS; Zhang WJ; Guo BY; Li JJ; Fu LM; Sun YP
    Anal Cell Pathol (Amst); 2022; 2022():2721005. PubMed ID: 35509814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necroptosis-Related miRNA Biomarkers for Predicting Overall Survival Outcomes for Endometrial Cancer.
    Song H; Li T; Sheng J; Li D; Liu X; Xiao H; Yu H; Liu W; Wang K; Chen Y
    Front Genet; 2022; 13():828456. PubMed ID: 35719379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma.
    Meng T; Wang Q; Yang Y; Ren Y; Shi Y
    Front Genet; 2022; 13():825261. PubMed ID: 35495130
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.
    Gao H; Xing F
    BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma.
    Xiang J; Gong W; Liu J; Zhang H; Li M; Wang R; Lv Y; Sun P
    Front Genet; 2023; 14():1098190. PubMed ID: 37274780
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of a novel necroptosis-associated miRNA signature for predicting the prognosis in head and neck squamous cell carcinoma.
    Guan J; Liu X; Wang K; Jia Y; Yang B
    Open Med (Wars); 2022; 17(1):1682-1698. PubMed ID: 36349193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
    Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y
    BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
    Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
    Front Immunol; 2022; 13():881359. PubMed ID: 35911752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of necroptosis-related gene signature to predict the prognosis of colon adenocarcinoma.
    Li M; Zhang T; Chen W
    Front Genet; 2022; 13():1051800. PubMed ID: 36353119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
    Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
    BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.